• 主题
高级搜索  >
历史搜索 清空历史
首页> 美国政府科技报告 >Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical211 Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of 211 the United States. Investigation No. 332-402
【24h】

Advice Concerning the Addition of Certain Pharmaceutical Products and Chemical211 Intermediates to the Pharmaceutical Appendix to the Harmonized Tariff Schedule of 211 the United States. Investigation No. 332-402

机译：关于将某些药品和化学品211中间体添加到美国211协调关税表的药品附录中的建议。第332-402号调查

获取原文
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

On January 13, 1999, at the request of the Office of the United States Trade211u001eRepresentative (USTR),the U.S. International Trade Commission (the Commission) 211u001einstituted investigation No. 332-402, Advice Concerning the Addition of Certain 211u001ePharmaceutical Products and Chemical Intermediates to the Pharmaceutical Appendix 211u001eto the Harmonized Tariff Schedule of the United States, pursuant to section 115 211u001eof the Uruguay Round Agreements Act and section 332(g) of the Tariff Act of 1930. 211u001eAs requested by USTR, the Commissions report on the investigation includes the 211u001efollowing information: A summary description of the products contained in the 211u001eexisting Pharmaceutical Appendix and the modifications to be made to that 211u001eappendix; An explanation of the relationship between the various elements in the 211u001ePharmaceutical Appendix and the Harmonized Tariff Schedule of the United States 211u001e(HTS); and An estimate of the current U.S. imports and, where possible, U.S. 211u001eexports of products included in the existing Pharmaceutical Appendix and the 211u001eproposed additions to the appendix, based on product groupings as necessary.

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号